Cargando…
A systematic review on use of aminoquinolines for the therapeutic management of COVID-19: Efficacy, safety and clinical trials
Recent global outbreak of the pandemic caused by coronavirus (COVID-19) emphasizes the urgent need for novel antiviral therapeutics. It can be supplemented by utilization of efficient and validated drug discovery approaches such as drug repurposing/repositioning. The well reported and clinically use...
Autores principales: | Patil, Vaishali M., Singhal, Shipra, Masand, Neeraj |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7211740/ https://www.ncbi.nlm.nih.gov/pubmed/32418894 http://dx.doi.org/10.1016/j.lfs.2020.117775 |
Ejemplares similares
-
Prospective mode of action of Ivermectin: SARS-CoV-2
por: Patil, Vaishali M., et al.
Publicado: (2022) -
Methaemoglobinaemia and the radical curative efficacy of 8-aminoquinoline antimalarials
por: White, Nicholas J, et al.
Publicado: (2022) -
4-Aminoquinoline compounds from the Spanish flu to COVID-19
por: Bazotte, Roberto Barbosa, et al.
Publicado: (2021) -
Antimalarials with Benzothiophene Moieties as Aminoquinoline Partners
por: Konstantinović, Jelena, et al.
Publicado: (2017) -
Aminoquinolines against coronavirus disease 2019 (COVID-19): chloroquine or hydroxychloroquine
por: Sahraei, Zahra, et al.
Publicado: (2020)